Testing a dye-guided method to find lung segments during surgery
Part of Cancer, Lungs & breathing clinical trials.
This trial studies a dye-based technique (using indocyanine green) to help surgeons identify lung segments during a lung cancer operation (segmentectomy). The goal is to improve how accurately and safely surgeons remove the affected part of the lung.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed stage I or II lung cancer, or a suspicious lung nodule
- You need a segmentectomy (lung area removal) because it’s best for cancer control or your heart/lung function makes a larger resection unsafe
- You’re 18 or older and can legally consent
- Your kidney and liver blood tests are within the trial’s limits
- You must not be allergic to the study dye or iodine
- You must be well enough for surgery and able to follow study instructions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two methods to help surgeons find the right section of the lung to remove during surgery. One method uses a special green dye, and the other uses air to inflate and deflate the lung. The goal is to find which is better at helping the surgeon remove only the sick part while saving healthy tissue.
This trial tests a single dose of a special dye (LS301-IT) that helps surgeons see lung cancer cells more clearly during surgery. It aims to make lung cancer removal more precise and complete.
This trial tests a new way to plan and guide lung cancer surgery using a special dye that shows the tumor area during the operation. It may help surgeons remove the cancer more accurately while targeting only a small section of lung for certain early-stage patients.
This trial tests a special imaging drug (IRDye800CW-nimotuzumab) that may help surgeons better see lung cancer tissue during planned lung surgery. Phase 1/2 looks mainly at safety and how well the imaging works to guide the operation.
This early-stage trial tests a robotic lung surgery that uses a special dye with near-infrared light to help the surgeon remove only the tumor area. If you have a small, early lung cancer, this approach may help improve accuracy while limiting how much lung is removed.
This trial tests a dye called abenacianine (VGT-309) that may help surgeons see cancer more clearly during lung surgery. It looks at whether the dye is safe and effective for identifying cancer in people having surgery to remove a lung lesion or mass.
Hear when a new Pulmonary Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.